Hzymes

"Hzymes" Each Molecule Promises Accuracy }
"Enzymes" catalyze the process of life
Hzymes History

Product Category

Molecular diagnostics

Hzymes Biotech providing molecular diagnostic raw materials with reliable and precise assays to the customers. Molecular diagnostics process, DNA purification, PCR, or testing material workflow must be rigorously monitored.

Immunodiagnosis

We develop, and manufacture innovative HEK293 cell stable expression platform & chemoenzymatic carbohydrate small molecule synthesis technology platform, it provides core raw materials for blood group detection, early cancer screening, companion diagnosis, chemiluminescence substrates and other fields.

Biochemical diagnosis

Hzymes Biotech has self-produced a whole series of key enzymes and raw materials that catalyze biochemical reactions for our biochemical assay kits. To meet different needs of our customers, we also provide customization service to modify and optimize enzyme properties tailoring to specific requirements.Biochemical diagnosis related products, including biochemical reagents, biochemical enzymes, biosensor POCT and general coenzymes.

Biopharma

Small nucleic acid drugs are in the stage of explosive growth. Nucleic acid drugs are leading the third revolution in biomedicine, mRNA, and siRNA in particular. Specializing in the R&D and production of glyco/nucleic acid products, we can provide nucleotides, glycol-enzymes, glycol-probes, and other glycol-related products.​

Hzymes Biotech

Hzymes Biotechnology Co., Ltd.
Hzymes Biotechs is a high-tech enterprise specializing in the research and development, production, application, and technical services of core raw materials for bio-medicine and in vitro diagnostics. Hzymes is determined to become a “world-class provider of unique enzyme products and services.” We consider the provision of key raw materials for the global bio-industry to be a professional responsibility and are eager to offer Hzymes Biotech resilience to human life in high-tech enterprises. R & D and production centers have been set up in Shanghai, Wuhan, Suzhou, Qingdao, and Yichang.
Company Vision
Become a world-class provider of special enzyme products and services
2022

1/621 Hzymes ranked in the 2022 Hurun Global Gazelle Enterprise Ranking;

1/4357 Hzymes won the title of "Little Giant" at the national level;

2022.10.17 Hzymes Open new Office Park;

2021

Strategic investment in Renxin Biotechnology, extending to innovative application platforms

In March, Institute of Key Raw Materials, Shanghai Institute of Experimental Medicine was jointly established;Hzymes Proteinase K won the annual innovative excellent product of China in vitro diagnostics

Hzymes specialized
Hzymes Biotech is committed to becoming a "world-class provider of special enzyme products & services". Contribute to the strength of Hzymes! Relying on five raw material enzyme creation technology platforms, Hzymes biotech can provide more than 300 kinds of core raw materials for in vitro diagnostics and biopharmaceuticals and "one-stop" solutions.
  • Molecular diagnosis
  • Immunodiagnosis
  • Biochemical diagnosis
  • Biopharma
  • Customized service
  • OEM Service
"Star of Creation" Gold Award
Quality Management System Certification
Environmental Management System Certification
3551 Optics Valley Talent Program Certificate of Honor
Intellectual Property Management System Certification
Hzymes is a high-tech enterprise specializing in the R&D, production, application and technical services of core raw materials for biomedicine and in vitro diagnostics. It is located in Shanghai, Wuhan, Suzhou, Qingdao and Yichang. Set up a R&D and production center. The company has technology platforms such as enzyme gene mining and performance characterization, enzyme molecular optimization and transformation, enzyme gene high-throughput screening, organic synthesis, synthetic biology, and antigen and antibody R&D and preparation. The company has technology platforms such as enzyme gene mining and performance characterization, enzyme molecular optimization and transformation, enzyme gene high-throughput screening, organic synthesis, synthetic biology, and antigen and antibody R&D and preparation.
  • R&D
  • Strategic cooperation
  • Product & Services
Yang Guangyu
chairman
Xie Yuan
General manager
Dr. Wang
Senior Researcher
Dr. Bian
Senior Researcher
Dr. Le
Senior Researcher
Dr. Lee
Senior Researcher
Dr. Wang
Senior Researcher
Dr. Yang
Senior Researcher
Dr. Zhou
Senior Researcher

Hzymes Biotech's Core Technology Platform​

Hzymes Biotech has nearly 20 years of technology accumulation, the only company in China that has 5 major IVD raw material enzyme creation technology platforms at the same time set up R&D and production bases in Wuhan, Shanghai, Suzhou, Qingdao and other cities to realize multi-technology platforms and multi-product fields. situation.

DNA

News

Hzymes New Building officially inaugurated.

Hzymes New Building officially inaugurated. January 1, 2022 October 17 is a milestone time for every Hzymes person to celebrate and remember. Hzymes Building in Shanghai Comprehensive Industrial Development Zone was…

Read More »